A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in Tsc1 null cells

被引:534
作者
Kwiatkowski, DJ [1 ]
Zhang, HB [1 ]
Bandura, JL [1 ]
Heiberger, KM [1 ]
Glogauer, M [1 ]
el-Hashemite, N [1 ]
Onda, H [1 ]
机构
[1] Harvard Univ, Brigham & Womens Hosp, Sch Med, Hematol Div,Genet Lab, Boston, MA 02115 USA
关键词
D O I
10.1093/hmg/11.5.525
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Tuberous sclerosis (TSC) is a autosomal dominant genetic disorder caused by mutations in either TSC1 or TSC2, and characterized by benign hamartoma growth. We developed a murine model of Tsc1 disease by gene targeting. Tsc1 null embryos die at mid-gestation from a failure of liver development. Tsc1 heterozygotes develop kidney cystadenomas and liver hemangiomas at high frequency, but the incidence of kidney tumors is somewhat lower than in Tsc2 heterozygote mice. Liver hemangiomas were more common, more severe and caused higher mortality in female than in male Tsc1 heterozygotes. Tsc1 null embryo fibroblast lines have persistent phosphorylation of the p70S6K (S6K) and its substrate S6, that is sensitive to treatment with rapamycin, indicating constitutive activation of the mTOR-S6K pathway due to loss of the Tsc1 protein, hamartin. Hyperphosphorylation of S6 is also seen in kidney tumors in the heterozygote mice, suggesting that inhibition of this pathway may have benefit in control of TSC hamartomas.
引用
收藏
页码:525 / 534
页数:10
相关论文
共 44 条
  • [11] Mutational and radiographic analysis of pulmonary disease consistent with lymphangioleiomyomatosis and micronodular pneumocyte hyperplasia in women with tuberous sclerosis
    Franz, DN
    Brody, A
    Meyer, C
    Leonard, J
    Chuck, G
    Dabora, S
    Sethuraman, G
    Colby, TV
    Kwiatkowski, DJ
    McCormack, FX
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2001, 164 (04) : 661 - 668
  • [12] TSC1 and TSC2 tumor suppressors antagonize insulin signaling in cell growth
    Gao, XS
    Pan, DJ
    [J]. GENES & DEVELOPMENT, 2001, 15 (11) : 1383 - 1392
  • [13] Regulation of translation initiation by FRAP/mTOR
    Gingras, AC
    Raught, B
    Sonenberg, N
    [J]. GENES & DEVELOPMENT, 2001, 15 (07) : 807 - 826
  • [14] Regulation of 4E-BP1 phosphorylation: a novel two-step mechanism
    Gingras, AC
    Gygi, SP
    Raught, B
    Polakiewicz, RD
    Abraham, RT
    Hoekstra, MF
    Aebersold, R
    Sonenberg, N
    [J]. GENES & DEVELOPMENT, 1999, 13 (11) : 1422 - 1437
  • [15] Gomez MR., 1999, TUBEROUS SCLEROSIS C
  • [16] LOSS OF HETEROZYGOSITY ON CHROMOSOME 16P13.3 IN HAMARTOMAS FROM TUBEROUS SCLEROSIS PATIENTS
    GREEN, AJ
    SMITH, M
    YATES, JRW
    [J]. NATURE GENETICS, 1994, 6 (02) : 193 - 196
  • [17] Tuberous sclerosis gene 2 product modulates transcription mediated by steroid hormone receptor family members
    Henry, KW
    Yuan, XJ
    Koszewski, NJ
    Onda, H
    Kwiatkowski, DJ
    Noonan, DJ
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (32) : 20535 - 20539
  • [18] Henske EP, 1996, AM J HUM GENET, V59, P400
  • [19] Gigas, a Drosophila homolog of tuberous sclerosis gene product-2, regulates the cell cycle
    Ito, N
    Rubin, GM
    [J]. CELL, 1999, 96 (04) : 529 - 539
  • [20] Clinical experience of lymphangioleiomyomatosis in the UK
    Johnson, SR
    Tattersfield, AE
    [J]. THORAX, 2000, 55 (12) : 1052 - 1057